Deficiency of Small Gtpase Rac2 Affects T Cell Activation
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Rac2 is a hematopoietic-specific GTPase acting as a molecular switch to mediate both transcriptional activation and cell morphological changes. We have examined the effect of Rac2 deficiency during T cell activation. In Rac2−/− T cells, proliferation was reduced upon stimulation with either plate-bound anti-CD3 or T cell receptor–specific antigen. This defect is accompanied with decreased activation of mitogen activated protein kinase extracellular signal–regulated kinase (ERK)1/2 and p38, and reduced Ca2+ mobilization. TCR stimulation–induced actin polymerization is also reduced. In addition, anti-CD3 cross-linking–induced T cell capping is reduced compared with wild-type T cells. These results indicate that Rac2 is important in mediating both transcriptional and cytoskeletal changes during T cell activation. The phenotypic similarity of Rac2−/− to Vav−/− cells implicates Rac2 as a downstream mediator of Vav signaling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation
Khosravi-Far, R., Solski, P. A., Clark, G. J., Kinch, M. S., & Der, C. J. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.11.6443 · Cited by 683
Roberts, A. W., Kim, C., Zhen, L., Lowe, J. B., Kapur, R., Petryniak, B., Spaetti, A., Pollock, J. D., Borneo, J. B., Bradford, G. B., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80019-9 · Cited by 556
Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes
Cox, D., Chang, P., Zhang, Q., Reddy, P. G., Bokoch, G. M., & Greenberg, S. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.9.1487 · Cited by 436
Activation of Phospholipase C-γ by Phosphatidylinositol 3,4,5-Trisphosphate
Bae, Y. S., Cantley, L. G., Chen, C.-S., Kim, S.-R., Kwon, K.-S., & Rhee, S. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4465 · Cited by 366 · cited 1×
“Recent studies suggests that phosphatidylinositol 3,4,5-trisphosphate (PIP3), a catalytic product of PI3K, can activate and synergize with phosphorylated PLC- to achieve full-scale Ca2 mobilization (55, 56).”
BackgroundCharacterization of RAC3, a Novel Member of the Rho Family
Haataja, L., Groffen, J., & Heisterkamp, N. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20384 · Cited by 243 · cited 1×
“Rac3 is a relative newly described member of Rac family and is highly expressed in brain (27).”
Background
Cited by
GTP‐binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo
Bustelo, X. R., Sauzeau, V., & Berenjeno, I. M. (2007) · BioEssays · doi:10.1002/bies.20558 · Cited by 634
The many paths to p38 mitogen-activated protein kinase activation in the immune system
Ashwell, J. D. (2006) · Nature Reviews Immunology · doi:10.1038/nri1865 · Cited by 370
Role of the cytoskeleton during leukocyte responses
Vicente-Manzanares, M., & Sánchez-Madrid, F. (2004) · Nature Reviews Immunology · doi:10.1038/nri1268 · Cited by 360
Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases
Salvador, J. M., Mittelstadt, P. R., Guszczynski, T., Copeland, T. D., Yamaguchi, H., Appella, E., Fornace, A. J., & Ashwell, J. D. (2005) · Nature Immunology · doi:10.1038/ni1177 · Cited by 306
“In another study it was shown that mice deficient in the hematopoietic-specific Rac2 protein demonstrate modestly reduced p38 activation after TCR crosslinkin”
BackgroundRho family GTPases and their regulators in lymphocytes
Tybulewicz, V. L. J., & Henderson, R. B. (2009) · Nature Reviews Immunology · doi:10.1038/nri2606 · Cited by 272
Rac signaling in breast cancer: A tale of GEFs and GAPs
Wertheimer, E., Gutierrez-Uzquiza, A., Rosemblit, C., Lopez-Haber, C., Sosa, M. S., & Kazanietz, M. G. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.08.011 · Cited by 203
Rho GTPases in hematopoiesis and hemopathies
Mulloy, J. C., Cancelas, J. A., Filippi, M.-D., Kalfa, T. A., Guo, F., & Zheng, Y. (2010) · Blood · doi:10.1182/blood-2009-09-198127 · Cited by 169
Rac2 Controls Tumor Growth, Metastasis and M1-M2 Macrophage Differentiation In Vivo
Joshi, S., Singh, A. R., Zulcic, M., Bao, L., Messer, K., Ideker, T., Dutkowski, J., & Durden, D. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095893 · Cited by 128
“Rac2-deficiency has also been shown to impact B- and T-cell migration, activation, development (to a lesser extent in T-cells) [9,10,11,12] and, in some reports, T-cell differentiation into T-helper type 1 (Th1) cells [9].”
BackgroundRac GTPase isoforms Rac1 and Rac2 play a redundant and crucial role in T-cell development
Guo, F., Cancelas, J. A., Hildeman, D., Williams, D. A., & Zheng, Y. (2008) · Blood · doi:10.1182/blood-2008-01-132068 · Cited by 100
Rac GTPases play critical roles in early T-cell development
Dumont, C., Corsoni-Tadrzak, A., Ruf, S., de Boer, J., Williams, A., Turner, M., Kioussis, D., & Tybulewicz, V. L. J. (2009) · Blood · doi:10.1182/blood-2008-09-181180 · Cited by 66
Park, H., Staehling-Hampton, K., Appleby, M. W., Brunkow, M. E., Habib, T., Zhang, Y., Ramsdell, F., Liggitt, H. D., Freie, B., Tsang, M., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080340 · Cited by 55
Hem-1: putting the "WAVE" into actin polymerization during an immune response
Park, H., Chan, M. M., & Iritani, B. M. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.10.018 · Cited by 36
RAC2 gain-of-function variants causing inborn error of immunity drive NLRP3 inflammasome activation
Doye, A., Chaintreuil, P., Lagresle-Peyrou, C., Batistic, L., Marion, V., Munro, P., Loubatier, C., Chirara, R., Sorel, N., Bessot, B., et al. (2024) · Journal of Experimental Medicine · doi:10.1084/jem.20231562 · Cited by 12
Metadata
- Authors
- Yu, H., Leitenberg, D., Li, B., & Flavell, R. A.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-09-24
- Volume
- 194
- Issue
- 7
- Pages
- 915-926
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1969632377
- Cited by
- 123
- References
- 5
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.